Aerie Pharmaceuticals to Participate in Three Investor Conferences in November
IRVINE, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (Nasdaq:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced that company management will present an overview of the company at the following conferences in November. Raymond James Fall Investor Conference Attendee: Vicente Anido, Jr., Ph.D., Chairman and Chief Executive Officer Date: Tuesday, November 15, 2016 Location: Boston,
